Published online Feb 6, 2020. doi: 10.12998/wjcc.v8.i3.504
Peer-review started: September 3, 2019
First decision: October 14, 2019
Revised: December 14, 2019
Accepted: December 21, 2019
Article in press: December 21, 2019
Published online: February 6, 2020
Processing time: 155 Days and 17.6 Hours
Surgical staples are widely used in all types of surgery. However, they are manufactured from non-biodegradable Ti or Ti alloys, meaning they exist permanently within the human body; this has resulted in reports of adverse effects, including allergic and foreign-body reactions and adhesion. Therefore, the development of biodegradable surgical staples is desirable. In order to develop a biodegradable alloy suitable for the fabrication of surgical staples, we focused on Zn, which is a known biodegradable metal. In this study, we developed novel Zn alloys with superior mechanical properties compared to the conventional Zn alloys that were suitable for fabricating surgical staples.
Zn has recently been the focus of research as a novel implant metal owing to its good biocompatibility and biodegradability. However, there are no extant reports on Zn-based staples owing to its low mechanical strength.
The objective of this study is to investigate the in vitro mechanical properties and degradation behaviors as well as in vivo safety and feasibility of biodegradable Zn alloy staples.
Tensile and bending tests were conducted to evaluate the mechanical properties of binary Zn alloys with 0.1–6 wt.% Mg, Ca, Mn, Cu, or Ti. Based on the results, three promising Zn alloy compositions were evaluated for staple applications (wt.%): Zn-1.0Cu-0.2Mn-0.1Ti (Zn alloy 1), Zn-1.0Mn-0.1Ti (Zn alloy 2), and Zn-1.0Cu-0.1Ti (Zn alloy 3). Immersion tests were performed using fed-state simulated intestinal fluid (FeSSIF) and Hank's balanced salt solution (HBSS). The corrosion rates were estimated from the weight losses of the staples during immersion. Nine rabbits were used as test subjects for gastric resection using each of the Zn alloy staples, and a clinically available Ti staple was used on another group of nine rabbits. Three rabbits in each group were euthanized at 1, 4, and 12 wk post operation.
Additions of ≤1 wt.% Mn or Cu and 0.1 wt.% Ti improved the yield strength without excessive deterioration of elongation or bendability. Immersion tests revealed no staple fractures in any of the Zn alloy staples. The corrosion rates of Zn alloy staples 1, 2, and 3 were 0.02 mm/year in HBSS and 0.12, 0.11, and 0.13 mm/year, respectively, in FeSSIF. These degradation times are sufficient for wound healing. In the animal study, none of the Zn alloy staples resulted in technical failures, and all rabbits survived without complications. Histopathological analysis revealed no severe inflammatory reactions around the Zn alloy staples.
Staples made of Zn-1.0Cu-0.2Mn-0.1Ti, Zn-1.0Mn-0.1Ti, and Zn-1.0Cu-0.1Ti exhibit acceptable in vitro mechanical properties, appropriate degradation behavior, and in vivo safety and feasibility.
Zn alloy staples are proposed as promising candidates for biodegradable staples to replace the currently available Ti alloy staple.